
Standard BioTools Inc
NASDAQ:LAB

Intrinsic Value
The intrinsic value of one
LAB
stock under the Base Case scenario is
0.64
USD.
Compared to the current market price of 1.05 USD,
Standard BioTools Inc
is
Overvalued by 39%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Standard BioTools Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Standard BioTools Inc
Balance Sheet Decomposition
Standard BioTools Inc
Current Assets | 344m |
Cash & Short-Term Investments | 258.1m |
Receivables | 35.5m |
Other Current Assets | 50.5m |
Non-Current Assets | 235.6m |
PP&E | 71m |
Intangibles | 139.8m |
Other Non-Current Assets | 24.8m |
Free Cash Flow Analysis
Standard BioTools Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Standard BioTools Inc
Revenue
|
169.7m
USD
|
Cost of Revenue
|
-89.9m
USD
|
Gross Profit
|
79.8m
USD
|
Operating Expenses
|
-206.1m
USD
|
Operating Income
|
-126.3m
USD
|
Other Expenses
|
-6.4m
USD
|
Net Income
|
-132.8m
USD
|
LAB Profitability Score
Profitability Due Diligence
Standard BioTools Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Score
Standard BioTools Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
LAB Solvency Score
Solvency Due Diligence
Standard BioTools Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Score
Standard BioTools Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LAB Price Targets Summary
Standard BioTools Inc
According to Wall Street analysts, the average 1-year price target for
LAB
is 2.42 USD
with a low forecast of 2.27 USD and a high forecast of 2.63 USD.
Dividends
Current shareholder yield for LAB is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
LAB
stock under the Base Case scenario is
0.64
USD.
Compared to the current market price of 1.05 USD,
Standard BioTools Inc
is
Overvalued by 39%.